Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (41-50 of 255) with videos related to

Pageof 26
Sort By:
Blood|September 22, 2005
NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145Sanja Vodanovic-Jankovic, Parameswaran Hari, Paulette Jacobs, et al.
Hematology/Oncology and Stem Cell Therapy|August 24, 2017
Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosisLindsay Hammons, Ruta Brazauskas, Marcelo Pasquini, et al.
Blood Advances|November 5, 2020
In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults"Pavan Reddy, Stella Davies, Navneet Majhail, et al.
British Journal of Haematology|May 12, 2010
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemiaHoratiu Olteanu, Alexandra M Harrington, Sarah Ramirez, et al.
Leukemia Research|June 28, 2021
Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantationMeera Mohan, Parameswaran Hari, Aniko Szabo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of diseaseNicholas L Wright, Kathryn E Flynn, Ruta Brazauskas, et al.
Leukemia|August 5, 2020
Salvage second transplantation in relapsed multiple myelomaBinod Dhakal, Anita D'Souza, Ariel Kleman, et al.
International Journal of Molecular Sciences|September 13, 2016
Development of Novel Immunotherapies for Multiple MyelomaEnsaf M Al-Hujaily, Robyn A A Oldham, Parameswaran Hari, et al.
BMC Medical Physics|May 7, 2009
Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow upRaymond Q Migrino, Richard Christenson, Aniko Szabo, et al.
Cardiovascular Ultrasound|August 9, 2008
Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiographyRaymond Q Migrino, Leanne Harmann, Timothy Woods, et al.
Pageof 26

Showing results (41-50 of 255) with videos related to

Sort By:
Pageof 26
Blood|September 22, 2005
NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145Sanja Vodanovic-Jankovic, Parameswaran Hari, Paulette Jacobs, et al.
Hematology/Oncology and Stem Cell Therapy|August 24, 2017
Presence of fluorescent in situ hybridization abnormalities is associated with plasma cell burden in light chain amyloidosisLindsay Hammons, Ruta Brazauskas, Marcelo Pasquini, et al.
Blood Advances|November 5, 2020
In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults"Pavan Reddy, Stella Davies, Navneet Majhail, et al.
British Journal of Haematology|May 12, 2010
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemiaHoratiu Olteanu, Alexandra M Harrington, Sarah Ramirez, et al.
Leukemia Research|June 28, 2021
Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantationMeera Mohan, Parameswaran Hari, Aniko Szabo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of diseaseNicholas L Wright, Kathryn E Flynn, Ruta Brazauskas, et al.
Leukemia|August 5, 2020
Salvage second transplantation in relapsed multiple myelomaBinod Dhakal, Anita D'Souza, Ariel Kleman, et al.
International Journal of Molecular Sciences|September 13, 2016
Development of Novel Immunotherapies for Multiple MyelomaEnsaf M Al-Hujaily, Robyn A A Oldham, Parameswaran Hari, et al.
BMC Medical Physics|May 7, 2009
Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow upRaymond Q Migrino, Richard Christenson, Aniko Szabo, et al.
Cardiovascular Ultrasound|August 9, 2008
Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiographyRaymond Q Migrino, Leanne Harmann, Timothy Woods, et al.
Pageof 26